AVBP

Conviction 100HealthcareScan · Thu, Jun 25, 2026

AVBP$33.86+5.73%

ResistanceSupportVol 14

Vol MA14 684.76K

Mar 26Apr 14May 1May 19Jun 8Jun 25

ArriVent BioPharma, Inc.PHARMACEUTICAL PREPARATIONSwww.arrivent.com ↗

Price33.86

Change+5.73%

Gap+1.28%

Rel volume3.28×

Avg volume746.37K

Avg $ vol23.45M

SMA 2030.97

SMA 5029.90

SMA 20023.66

Price vs 50+13.21%

Price vs 200+43.10%

MA stackbullish

50/200 cross—

Supertrendup · 28.30

RSI (14)64

MACD hist0.26

MACD cross—

Stoch %K / %D86 / 74

ADX (14)31

+DI / −DI26 / 11

RSI divergenceBearish

MACD divergence—

ATR %+5.43%

ADR %6.19%

52w high33.86

52w low16.95

From 52w high+0.00%

Above 52w low+99.73%

New 52w highYes

SqueezeOff

Bollinger width19.82%

%B0.97

Donchian pos90.11%

Donchian high34.65

Donchian low26.61

AVWAP (52w high)33.32

vs AVWAP high+1.60%

AVWAP (52w low)24.20

vs AVWAP low+39.91%

OBV trendUp

Chaikin MF (20)0.05

Today vs 20d3.28×

Avg vol (14d)684.75K

Avg vol (20d)746.37K

Avg $ vol (20d)23.45M

Market cap1.58B

RS 3m (vs SPY)+33.62%

RS 6m (vs SPY)+37.74%

RS line new highNo

Trend template8/8

Technical rank91.5

1 week+7.96%

1 month+21.17%

3 months+48.81%

6 months+51.14%

1 year+46.50%

YTD+62.76%

P/E-9.48

P/B4.87

P/S—

P/FCF—

EPS-4.32

Div yield—

ROE-51.33%

ROA-47.61%

Debt/Eq—

Current13.95

EV/EBITDA-8.39

Gross margin—

Net margin—

Rev growth—

EPS growth-106.62%

Price target43.08

Target upside27.25%

Analyst ratingBuy

Institutional94.43%

Ent. value1.51B

Revenue—

Net income-43.32M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out46.57M

Employees77

ListedFri, Jan 26, 2024

Free float21.68M

Float %52.5%

Short interest7.71M

Days to cover14.4d

Short volume19.1%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.96 vs −$0.88

Last surprise-9.1% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank91.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance34.13

Support26.26

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVBP

All disclosures →

No recent disclosed trades by Congress in AVBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVBP · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Nolet Chris Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Hohneker John Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Peterson Kristine Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Parsey Merdad Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in AVBP · 1 recent

EDGAR →

8-K8-KMon, Jun 22, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.